Stock Market News1 month GILD Obtains Positive CHMP Opinion for Liver Disease Drug Zacks
The CHMP recommends the approval of Gilead’s seladelpar in combination with ursodeoxycholic acid for the treatment of primary biliary cholangitis in adults.
XThe CHMP recommends the approval of Gilead’s seladelpar in combination with ursodeoxycholic acid for the treatment of primary biliary cholangitis in adults.
X